CHEMCRUXChemcrux Enterprises Limited
Chemicals · Specialty Chemicals · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
Chemcrux Enterprises Limited engages in the manufacture and sale of intermediates and chemicals in India. Its chemicals and intermediates products are used in the manufacture of bulk drugs active pharmaceutical ingredients, electro-plating, pharmaceuticals, dyes, and pigments. The company offers chloro benzoic acid, nitro benzoic acid, nitro salicylic, dichloro benzoic acid, chloro nitro benzoic acid, lasamide, arabonic acid sodium salt, chloro benzoic acid sulfonamide, BPEA sulfonamide, para and ortho chloro benzoyl chloride, and chloro benzoyl chloride. It serves multinationals and pharmaceutical organizations. The company also exports its products. Chemcrux Enterprises Limited was founded in 1983 and is based in Vadodara, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on CHEMCRUX — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
The picture
- • Revenue growth: 32.9% YoY
- • Profit growth: 466.7% YoY
- • Debt/Equity: 0.45
- • Distance from 52-week high: 7.7% below high
- • Max drawdown (1y): 7%
- • Beta: 0.50
Bull case
- • Revenue growth: 32.9% YoY
- • Profit growth: 466.7% YoY
- • Debt/Equity: 0.45
- • Distance from 52-week high: 7.7% below high
Bear case
- • Recently listed — limited trading history, scores are provisional
- • ROE: 4.9%
- • ROCE: 5.8%
- • Insufficient price history
Key risks
- • Recently listed — limited trading history, scores are provisional
- • ROE: 4.9%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹3.51). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.